Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Chongqing Medical UniversityActive in the last 2 years

Jianping Gong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5926-7944; OpenAlex author ID A5075676648. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 4 papers · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 13

  1. Prognostic biomarker MICAL2 and associates with proliferation, migration and immune infiltration in pancreatic adenocarcinoma. Last author DOI 10.1007/s13353-024-00919-3↗
  2. Ultra-processed food consumption and the risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Co-author DOI 10.1002/ijc.34290↗
  3. The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis. Co-author DOI 10.1186/s12876-023-02671-0↗
  4. Fried food consumption and the risk of pancreatic cancer: A large prospective multicenter study. Co-author DOI 10.3389/fnut.2022.889303↗
  5. HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway. Last author DOI 10.7150/ijbs.70546↗
  6. Type 2 diabetes prevention diet and the risk of pancreatic cancer: A large prospective multicenter study. Co-author DOI 10.1016/j.clnu.2021.09.037↗
  7. Dietary Vitamin K Intake and the Risk of Pancreatic Cancer: A Prospective Study of 101,695 American Adults. Co-author DOI 10.1093/aje/kwab131↗
  8. Total Antioxidant Capacity and Pancreatic Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Last author DOI 10.1158/1055-9965.epi-19-1511↗
  9. Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature review. Co-author DOI 10.1186/s12876-020-01420-x↗
  10. Misdiagnosed as pancreatic cancer seven years ago, a 29-year-old woman suffered from left-sided portal hypertension caused by peripancreatic lymph node tubercu… Co-author DOI 10.21203/rs.3.rs-16647/v1↗
  11. High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/mmr.2019.10869↗
  12. Identification of key pathways and candidate genes in pancreatic ductal adenocarcinoma using bioinformatics analysis. Co-author DOI 10.3892/ol.2019.10041↗
  13. Oncogenesis and the clinical significance of K-ras in pancreatic adenocarcinoma. Co-author DOI 10.7314/apjcp.2013.14.5.2699↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie‐Jun Hu · 5 shared papers, 2020–2023 · strength 0.78
  2. Guo‐Chao Zhong · 5 shared papers, 2020–2023 · strength 0.76
  3. Huachao Yang · 1 shared paper, 2025 · strength 0.42
  4. Weiping Sun · 2 shared papers, 2021–2023 · strength 0.33
  5. Dajun Yu · 2 shared papers, 2020 · strength 0.27
  6. Jinzheng Li · 2 shared papers, 2020 · strength 0.27
  7. Pengfei Yang · 2 shared papers, 2021 · strength 0.27
  8. Hong-Dan Fan · 1 shared paper, 2023 · strength 0.26
  9. Qing-Song Mao · 1 shared paper, 2023 · strength 0.26
  10. Jian Kun Hu · 1 shared paper, 2023 · strength 0.26
  11. Junhua Gong · 1 shared paper, 2022 · strength 0.17
  12. Li He · 1 shared paper, 2020 · strength 0.16
  13. Wu Wu · 1 shared paper, 2022 · strength 0.15
  14. Yan Liu · 1 shared paper, 2022 · strength 0.15
  15. Menghao Wang · 1 shared paper, 2022 · strength 0.15
  16. Zhu Zhu · 1 shared paper, 2022 · strength 0.15
  17. Yan Jiun Huang · 1 shared paper, 2021 · strength 0.14
  18. Zhi Li · 1 shared paper, 2021 · strength 0.14
  19. Dao-Wu Yu · 1 shared paper, 2021 · strength 0.13
  20. Yiping He · 1 shared paper, 2019 · strength 0.11
  21. Hao Wu · 1 shared paper, 2019 · strength 0.11
  22. Zhujun Yi · 1 shared paper, 2020 · strength 0.11
  23. Kang Yang · 1 shared paper, 2013 · strength 0.05
  24. Chun Huang · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.